Clinical Trials Browser

Phase 4 × INDUSTRY × Squamous Intraepithelial Lesions × Clear all

NCT05916911 2024-02-07

Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)

Phase 4 Unknown

Squamous Intraepithelial Lesions, Papillomavirus Infections